RhoFED CDSMC supports safe, efficient clinical trials for allergic and autoimmune diseases
Official title: RhoFED CDSMC
Funded at Rho Federal Systems Division, INC. · NIH-11595621 · Data updated 2026-11-12
A dedicated center helps manage and safeguard clinical research on allergy, asthma, autoimmune diseases, and immune-related transplant issues so patients can benefit from better, safer trials.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Rho Federal Systems Division, INC. NIH-funded |
| Lab location | 1 site (Durham, UNITED STATES) |
| Project start | May 8, 2023 |
| Project end | April 30, 2028 |
| Funding year | 2026 |
| Award (this year) | $45,450 |
| NIH project number | 3U01AI178773-04S1 |
| Project ID | NIH-11595621 on NIH RePORTER |
Who could benefit from this research
✓Could help
Patients enrolled in NIAID-supported clinical trials for allergic diseases, asthma, autoimmune disorders, or immune-related transplant complications.
✕Less likely to help
Patients not participating in NIAID-supported trials or whose conditions are not currently studied may not directly benefit.
What this research studies
The NIAID Clinical Data and Safety Management Center coordinates data, safety events, and biospecimen tracking for trials in allergic diseases, asthma, and autoimmunity. It focuses on modernizing trial operations with up-to-date data systems while maintaining steady, careful adoption of new technologies. The center provides administrative, data-management, safety, and specimen-tracking support to improve the quality and safety of patient-involved research. This program has evolved over two decades to keep trial practices aligned with current standards and patient safety needs.
Why it matters
Potential benefit: If successful, patients could participate in higher-quality trials with safer data handling and better coordination across studies.
How similar studies have gone: Historical collaboration has reduced safety risks and improved data quality in large-scale allergy/autoimmune trials, with ongoing evolution to adopt better systems.
Where this research is happening
-
Rho Federal Systems Division, INC.
Durham, United States Active
Researchers
- Principal investigator: Dunaway, Lars — Rho Federal Systems Division, INC.
- Study coordinator: Dunaway, Lars
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.